We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future drug authorisations in the wake of Brexit.